Vascular Impact of Cancer Therapies: The Case of BTK (Bruton Tyrosine Kinase) Inhibitors. Fleming MR, Xiao L, Jackson KD, Beckman JA, et al. Circ Res 2021;128:1973-1987.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fleming MR, Xiao L, Jackson KD, Beckman JA, et al. Vascular Impact of Cancer Therapies: The Case of BTK (Bruton Tyrosine Kinase) Inhibitors. Circ Res 2021;128:1973-1987.
PMID: 34110908